Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Journal of the American Society of NephrologyOpen Access

Novel Biomarkers in CKD

View Full Paper
Ask AI
Bookmark
Share

Authors

BLBo LiangFLFu‐Rong LiLLLiang Liu

Discussion

Loading...

Member takes

Overview

Observational analysis identifies 21 novel biomarkers for CKD progression, suggesting implications for personalized medicine.

Key Points

  • The identification of 21 novel biomarkers improves understanding of kidney injury, inflammation, and cardiovascular disease.
  • Key biomarkers include UCOL1A1, sTNFR1, and hs-cTnT, showing good discrimination for CKD progression.
  • The predominantly White cohort raises concerns about generalizability to diverse populations in CKD research.
  • Future studies need to validate findings and explore dynamic biomarker changes with newer CKD therapies.

Cite This Study

Liang et al. (2025) studied this question.

synapsesocial.com/papers/68c23c20b210217d6478866bhttps://doi.org/10.1681/asn.0000000846
View Full Paper
Ask AI
Bookmark
Share